Chinese regulator surprises pharma with clinical data self-audit notice
This article was originally published in SRA
Executive Summary
A China Food and Drug Administration announcement released on July 22 is requiring the drug applicants in over 1,600 pending product approvals to conduct self-audits of the clinical data and submit an electronic version of the reports to the CFDA’s Center for Drug and Food Inspection1.